Chronic kidney disease in women


Cite item

Full Text

Abstract

Risk factors and treatment strategy of chronic kidney disease are discussed

About the authors

N A Mukhin

N A Moukhin

References

  1. Coresh J., Selvin E., Stevens L.A. et al. Prevalence of chronic kidney disease in the United States. J.A.M.A. 2007; 298(17): 2038-2047
  2. McCullough P.A., Li S., Jurkovitz CT. et al. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am. J. Kidney Dis. 2008; 51 (4 Suppl 2): S38-S45
  3. Rao M.V., Qiu Y., Wang C., Bakris G. Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004. Am. J. Kidney Dis. 2008; 51 (4 Suppl. 2): S30-S37
  4. Whaley-Connell A.T., Sowers J.R., McFarlane S.I. et al.; Kidney Early Evaluation Program Investigators. Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004. Am. J. Kidney Dis. 2008; 51 (4 Suppl. 2): S21-S29
  5. Chrysohoou C., Panagiotakos D.B., Pitsavos C. et al. Renal function, cardiovascular disease risk factors' prevalence and 5-year disease incidence; the role of diet, exercise, lipids and inflammation markers: the ATTICA study. Q.J.M. 2010 Apr 7. [Epub ahead of print]
  6. Orth S.R. Smoking and the kidney. J. Am. Soc. Nephrol. 2002; 13(6): 1663-1672
  7. Hogan S.L., Vupputuri S., Guo X. et al. Association of cigarette smoking with albuminuria in the United States: the third National Health and Nutrition Examination Survey. Ren. Fail. 2007; 29(2): 133-142
  8. Jones-Burton C., Seliger S.L., Scherer R.W. et al. Cigarette smoking and incident chronic kidney disease: a systematic review. Am. J. Nephrol. 2007; 27(4): 342-351
  9. Centers for Disease Control and Prevention (CDC). Smoking prevalence among women of reproductive age - United States, 2006. MMWR Morb. Mortal. Wkly. Rep. 2008; 57(31): 849-852
  10. Kenfield S.A., Stampfer M.J., Rosner B.A., Colditz G.A. Smoking and smoking cessation in relation to mortality in women. J.A.M.A. 2008; 299(17): 2037-2047
  11. Cui Y., Miller A.B., Rohan T.E. Cigarette smoking and breast cancer risk: update of a prospective cohort study. Breast Cancer Res. Treat. 2006; 100(3): 293-299
  12. Young E., Leatherdale S., Sloan M. et al. Age of smoking initiation and risk of breast cancer in a sample of Ontario women. Tob. Induc. Dis. 2009; 5(1): 4
  13. Castellanos M., Varma S., Ahern K. Increased breast calcifications in women with ESRD on dialysis: implications for breast cancer screening. Am. J. Kidney Dis. 2006; 48(2): 301-306
  14. Castellanos M.R., Paramanathan K., El-Sayegh S. et al. Breast cancer screening in women with chronic kidney disease: the unrecognized effects of metastatic soft-tissue calcification. Nat. Clin. Pract. Nephrol. 2008; 4(6): 337-341
  15. LeBrun C.J., Diehl L.F., Abbott K.C. et al. Life expectancy benefits of cancer screening in the end-stage renal disease population. Am. J. Kidney Dis. 2000; 35(2): 237-243
  16. Мухин Н.А., Сагинова Е.А., Фомин В.В. и др. Эндотелиальная дисфункция и поражение почек при ожирении. Вестник РАМН 2006; 12: 25-31
  17. Wang Y., Chen X., Song Y. et al. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int. 2008; 73(1): 19-33
  18. Noori N., Hosseinpanah F., Nasiri A.A., Azizi F. Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J. Ren. Nutr. 2009; 19(3): 228-237
  19. Чазова И.Е., Мычка В.Б. Метаболический синдром. М.: Media Medica, 2004
  20. Elsayed E.F., Sarnak M.J., Tighiouart H. et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am. J. Kidney Dis. 2008; 52(1): 29-38
  21. Шальнова С.А., Деев А.Д. Масса тела у мужчин и женщин (результаты обследования российской национальной представительной выборки населения). Кардиоваскулярная терапия и профилактика 2008; 7(6): 60 - 63
  22. Domrongkitchaiporn S., Sritara P., Kitiyakara C. et al. Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J. Am. Soc. Nephrol. 2005; 16: 791 - 799
  23. Taylor E.N., Stampfer M.J., Curhan G.C. Obesity, weight gain, and the risk of kidney stones. J.A.M.A. 2005; 293(4): 455-462
  24. Мухин Н.А., Балкаров И.М., Шоничев Д.Г., Лебедева М.В. Формирование артериальной гипертонии при хроническом уратном тубуло-интерстициальном нефрите. Тер. арх. 1999; 71(6): 23-27
  25. Nagahama K., Inoue T., Iseki K. et al. Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens. Res. 2004; 27(11): 835-841
  26. Bellomo G., Venanzi S., Verdura C. et al. Association of uric acid with change in kidney function in healthy normotensive individuals. Am. J. Kidney Dis. 2010 Apr 10. [Epub ahead of print]
  27. Tyler D.E. Urinalysis and urine cytology correlated with the menstrual cycle and age. Am. J. Obstet. Gynecol. 1964; 90: 147-154
  28. Agarwal M., Selvan V., Freedman BI. et al. The relationship between albuminuria and hormone therapy in postmenopausal women. Am. J. Kidney Dis. 2005; 45(6): 1019-1025
  29. Фомина И.Г., Брагина А.Е., Гайдамакина Н.Е., Салимжанова Ю.Н. Особенности почечной гемодинамики и состояния клубочковой фильтрации у мужчин и женщин, больных эссенциальной артериальной гипертензией, в возрасте 40-60 лет. Рациональная фармакотерапия в кардиологии. 2007; 5: 69-72
  30. Подзолков В.И., Брагина А.Е., Родионова Ю.Н. Влияние табакокурения на состояние почечной и центральной гемодинамики у мужчин и женщин с эссенциальной артериальной гипертензией. Кардиоваскулярная терапия и профилактика. 2009; 8 (6): 10-15
  31. Shantha G.P., Kumar A.A., Bharadhi M.K., Arthur P. Role of gender in the associations of microalbuminuria with inflammatory markers in hypertensive subjects: a cross-sectional study. Kidney Blood Press. Res. 2009; 32(6): 434-439
  32. Zheng F., Plati A.R., Potier M. et al. Resistance to glomerulosclerosis in B6 mice disappears after menopause. Am. J. Pathol. 2003; 162(4): 1339-1348
  33. Schopick E.L., Fisher N.D., Lin J. et al. Post-menopausal hormone use and albuminuria. Nephrol. Dial. Transplant. 2009; 24(12): 3739-3744
  34. Hadjadj S., Gourdy P., Zaoui P. et al.; RADIAN Study Group. Effect of raloxifene - a selective oestrogen receptor modulator - on kidney function in post-menopausal women with Type 2 diabetes: results from a randomized, placebo-controlled pilot trial. Diabet. Med. 2007; 24(8): 906-910
  35. Machado R.B., Careta M.F., Balducci G.P. et al. Effects of estrogen therapy on microalbuminuria in healthy post-menopausal women. Gynecol. Endocrinol. 2008; 24(12): 681-685
  36. Manning P.J., Sutherland W.H., Allum A.R. et al. HRT does not improve urinary albumin excretion in postmenopausal diabetic women. Diabetes Res. Clin. Pract. 2003; 60(1): 33-39
  37. Чазова И.Е., Сметник В.П., Балан В.Е. и др. Ведение женщин с сердечно-сосудистым риском в пери- и постменопаузе: консенсус российских кардиологов и гинекологов. Системные гипертензии. 2008; 3: 26-39
  38. Archer D.F. Drospirenone-containing hormone therapy for postmenopausal women. Perspective on current data. J. Reprod. Med. 2007; 52(2 Suppl): 159-164
  39. White W.B. Drospirenone with 17beta-estradiol in the postmenopausal woman with hypertension. Climacteric. 2007; 10 (Suppl 1): 25-31
  40. Preston R.A., Norris P.M., Alonso A.B. et al. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide. Menopause. 2007;14 (3 Pt 1): 408-414
  41. Pannacciulli N., Cantatore F.P., Minenna A. et al. Urinary albumin excretion is independently associated with C-reactive protein levels in overweight and obese nondiabetic premenopausal women. J. Intern. Med. 2001; 250(6): 502-507
  42. Lloyd-Jones D.M., Evans J.C., Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. J.A.M.A. 2005; 294(4): 466-472
  43. Yamori Y., Liu L., Ikeda K. et al.; WHO Cardiovascular Diseases and Alimentary Comparison (WHO-CARDIAC) Study. Different associations of blood pressure with 24-hour urinary sodium excretion among pre- and post-menopausal women. WHO Cardiovascular Diseases and Alimentary Comparison (WHO-CARDIAC) Study. J. Hypertens. 2001; 19 (3 Pt. 2): 535-538
  44. Vikse B.E., Irgens L.M., Leivestad T. et al. Preeclampsia and the risk of end-stage renal disease. N. Engl. J. Med. 2008; 359(8): 800-809
  45. Spaan J.J., Ekhart T., Spaanderman M.E., Peeters L.L. Remote hemodynamics and renal function in formerly preeclamptic women. Obstet. Gynecol. 2009; 113(4): 853-859
  46. Козловская Н.Л. Нефропатия, ассоциированная с первичным антифосфолипидным синдромом: клинико-морфологическая характеристика, диагностика, лечение. Автореф. дисс. докт. М., 2006
  47. Sinico R.A., Cavazzana I., Nuzzo M. et al. Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 Patients. Clin. J. Am. Soc. Nephrol. 2010 Apr 29. [Epub ahead of print]
  48. Тареева И.Е., Шилов Е.М., Краснова Т.Н. и др. Волчаночный нефрит в середине XX века и в начале XXI века. Тер. арх. 2001; 73(6): 5 - 10
  49. Contreras G <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Contreras%20G%22%5BAuthor%5D>., Roth D <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Roth%20D%22%5BAuthor%5D>., Pardo V <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Pardo%20V%22%5BAuthor%5D>. et al. Lupus nephritis: a clinical review for practicing nephrologists. Clin. Nephrol. <javascript:AL_get(this,%20'jour',%20'Clin%20Nephrol.');> 2002; 57(2): 95-107
  50. Cochrane R., Regan L. Undetected gynaecological disorders in women with renal disease. Human Reproduction. 1997; 12(4): 667 - 670
  51. Pinter I., Matyus J., Czegany Z. et al. Analgesic nephropathy in Hungary: the HANS study. Nephrol. Dial. Transplant. 2004; 19: 840 - 843
  52. Forman J.P., Stampfer M.J., Curhan G.C. Non-narcotic analgesic dose and risk of incident hypertension in US women. Hypertension. 2005; 46(3): 500-507
  53. Fischer M.J. Chronic kidney disease and pregnancy: maternal and fetal outcomes. Adv. Chronic Kidney Dis. 2007; 14(2): 132-145

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies